Skip to main content
In stock|Hormonal Therapy

Histrelin

Oncology TypeSolid Tumour (Prostate/Breast)
Drug Class / MechanismLHRH Agonist
No Image
Description

Histrelin is classified as a LHRH Agonist, sourced for use within our Hormonal Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryHormonal Therapy
Oncology TypeSolid Tumour (Prostate/Breast)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3